Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 7;10(1):e0004210.
doi: 10.1371/journal.pntd.0004210. eCollection 2016 Jan.

Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals

Affiliations
Review

Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals

Jessica R Spengler et al. PLoS Negl Trop Dis. .

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a widely distributed, tick-borne viral disease. Humans are the only species known to develop illness after CCHF virus (CCHFV) infection, characterized by a nonspecific febrile illness that can progress to severe, often fatal, hemorrhagic disease. A variety of animals may serve as asymptomatic reservoirs of CCHFV in an endemic cycle of transmission. Seroepidemiological studies have been instrumental in elucidating CCHFV reservoirs and in determining endemic foci of viral transmission. Herein, we review over 50 years of CCHFV seroepidemiological studies in domestic and wild animals. This review highlights the role of livestock in the maintenance and transmission of CCHFV, and provides a detailed summary of seroepidemiological studies of wild animal species, reflecting their relative roles in CCHFV ecology.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Geographic summary of countries represented in CCHFV seroepidemiological surveys.
Countries with evidence of seroprevalence in animals represented in blue, countries with absence of seroprevalence represented in green, and countries without reported serosurveys represented in grey.
Fig 2
Fig 2. Total international CCHFV seroprevalence reported in domestic animals by species.
Seroprevalence determined by sum of seropositive animals over the sum of total animals, sampled internationally. Studies that did not report sample numbers or differentiate between types of animal were excluded.

References

    1. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100: 159–89. 10.1016/j.antiviral.2013.07.006 - DOI - PubMed
    1. Ergonul O. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol. Elsevier B.V.; 2012;2: 215–20. 10.1016/j.coviro.2012.03.001 - DOI - PubMed
    1. Ceylan B, Calica A, Ak O, Akkoyunlu Y, Turhan V. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: Observations from the Turkish experience. Int J Infect Dis. International Society for Infectious Diseases; 2013;17: e799–e801. 10.1016/j.ijid.2013.02.030 - DOI - PMC - PubMed
    1. Arda B, Aciduman A, Johnston JC. A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations. J Med Ethics. 2012;38: 117–120. 10.1136/medethics-2011-100107 - DOI - PubMed
    1. Nalca A, Whitehouse CA. Crimean-Congo hemorrhagic fever virus infection among animals In: Ergonul O, Whitehouse C, editors. Crimean–Congo Hemorrhagic Fever: A Global Perspective. Dordrecht, Netherlands: Springer; 2007. pp. 155–165.

Publication types